Exact Mass: 563.2519

Exact Mass Matches: 563.2519

Found 32 metabolites which its exact mass value is equals to given mass value 563.2519, within given mass tolerance error 0.001 dalton. Try search metabolite list with more accurate mass tolerance error 0.0002 dalton.

Alpha-Hydroxy-tamoxifen-O-glucuronide

(2S,3S,4S,5R,6S)-6-{[(2-{4-[(1Z)-1,2-diphenylbut-1-en-1-yl]phenoxy}ethyl)(methyl)amino]methoxy}-3,4,5-trihydroxyoxane-2-carboxylic acid

C32H37NO8 (563.2519)


Alpha-Hydroxy-tamoxifen-O-glucuronide is a metabolite of tamoxifen. Tamoxifen is an antagonist of the estrogen receptor in breast tissue via its active metabolite, hydroxytamoxifen. In other tissues such as the endometrium, it behaves as an agonist, and thus may be characterized as a mixed agonist/antagonist. Tamoxifen is the usual endocrine therapy for hormone receptor-positive breast cancer in pre-menopausal women, and is also a standard in post-menopausal women although aromatase inhibitors are also frequently used in that setting. (Wikipedia)

   

4-Hydroxytamoxifen-O-glucuronide

(2R,3R,4R,5S)-6-{4-[(1Z)-1-{4-[2-(dimethylamino)ethoxy]phenyl}-2-phenylbut-1-en-1-yl]phenoxy}-3,4,5-trihydroxyoxane-2-carboxylic acid

C32H37NO8 (563.2519)


4-Hydroxytamoxifen-O-glucuronide is a metabolite of tamoxifen. Tamoxifen is an antagonist of the estrogen receptor in breast tissue via its active metabolite, hydroxytamoxifen. In other tissues such as the endometrium, it behaves as an agonist, and thus may be characterized as a mixed agonist/antagonist. Tamoxifen is the usual endocrine therapy for hormone receptor-positive breast cancer in pre-menopausal women, and is also a standard in post-menopausal women although aromatase inhibitors are also frequently used in that setting. (Wikipedia)

   

(E)-3-Hydroxy Tamoxifen O-|A-D-Glucuronide

6-[3-(1-{4-[2-(dimethylamino)ethoxy]phenyl}-2-phenylbut-1-en-1-yl)phenoxy]-3,4,5-trihydroxyoxane-2-carboxylic acid

C32H37NO8 (563.2519)


   

Tamoxifen citrate

Tamoxifen Citrate (Nolvadex)

C32H37NO8 (563.2519)


D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D020847 - Estrogen Receptor Modulators D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D004965 - Estrogen Antagonists C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C1821 - Selective Estrogen Receptor Modulator C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C61074 - Serine/Threonine Kinase Inhibitor C274 - Antineoplastic Agent > C129818 - Antineoplastic Hormonal/Endocrine Agent > C481 - Antiestrogen C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C483 - Therapeutic Estrogen C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist D050071 - Bone Density Conservation Agents D000970 - Antineoplastic Agents C1892 - Chemopreventive Agent

   

Cys Lys Gln Trp

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2R)-2-amino-3-sulfanylpropanamido]hexanamido]-4-carbamoylbutanamido]-3-(1H-indol-3-yl)propanoic acid

C25H37N7O6S (563.2526)


   

Cys Lys Trp Gln

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2R)-2-amino-3-sulfanylpropanamido]hexanamido]-3-(1H-indol-3-yl)propanamido]-4-carbamoylbutanoic acid

C25H37N7O6S (563.2526)


   

Cys Gln Lys Trp

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-4-carbamoylbutanamido]hexanamido]-3-(1H-indol-3-yl)propanoic acid

C25H37N7O6S (563.2526)


   

Cys Gln Trp Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-4-carbamoylbutanamido]-3-(1H-indol-3-yl)propanamido]hexanoic acid

C25H37N7O6S (563.2526)


   

Cys Trp Lys Gln

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-(1H-indol-3-yl)propanamido]hexanamido]-4-carbamoylbutanoic acid

C25H37N7O6S (563.2526)


   

Cys Trp Gln Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-(1H-indol-3-yl)propanamido]-4-carbamoylbutanamido]hexanoic acid

C25H37N7O6S (563.2526)


   

Lys Cys Gln Trp

(2S)-2-[(2S)-4-carbamoyl-2-[(2R)-2-[(2S)-2,6-diaminohexanamido]-3-sulfanylpropanamido]butanamido]-3-(1H-indol-3-yl)propanoic acid

C25H37N7O6S (563.2526)


   

Lys Cys Trp Gln

(2S)-4-carbamoyl-2-[(2S)-2-[(2R)-2-[(2S)-2,6-diaminohexanamido]-3-sulfanylpropanamido]-3-(1H-indol-3-yl)propanamido]butanoic acid

C25H37N7O6S (563.2526)


   

Lys Gln Cys Trp

(2S)-2-[(2R)-2-[(2S)-4-carbamoyl-2-[(2S)-2,6-diaminohexanamido]butanamido]-3-sulfanylpropanamido]-3-(1H-indol-3-yl)propanoic acid

C25H37N7O6S (563.2526)


   

Lys Gln Trp Cys

(2R)-2-[(2S)-2-[(2S)-4-carbamoyl-2-[(2S)-2,6-diaminohexanamido]butanamido]-3-(1H-indol-3-yl)propanamido]-3-sulfanylpropanoic acid

C25H37N7O6S (563.2526)


   

Lys Trp Cys Gln

(2S)-4-carbamoyl-2-[(2R)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-(1H-indol-3-yl)propanamido]-3-sulfanylpropanamido]butanoic acid

C25H37N7O6S (563.2526)


   

Lys Trp Gln Cys

(2R)-2-[(2S)-4-carbamoyl-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-(1H-indol-3-yl)propanamido]butanamido]-3-sulfanylpropanoic acid

C25H37N7O6S (563.2526)


   

Gln Cys Lys Trp

(2S)-2-[(2S)-6-amino-2-[(2R)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-sulfanylpropanamido]hexanamido]-3-(1H-indol-3-yl)propanoic acid

C25H37N7O6S (563.2526)


   

Gln Cys Trp Lys

(2S)-6-amino-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-sulfanylpropanamido]-3-(1H-indol-3-yl)propanamido]hexanoic acid

C25H37N7O6S (563.2526)


   

Gln Lys Cys Trp

(2S)-2-[(2R)-2-[(2S)-6-amino-2-[(2S)-2-amino-4-carbamoylbutanamido]hexanamido]-3-sulfanylpropanamido]-3-(1H-indol-3-yl)propanoic acid

C25H37N7O6S (563.2526)


   

Gln Lys Trp Cys

(2R)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-4-carbamoylbutanamido]hexanamido]-3-(1H-indol-3-yl)propanamido]-3-sulfanylpropanoic acid

C25H37N7O6S (563.2526)


   

Gln Trp Cys Lys

(2S)-6-amino-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-(1H-indol-3-yl)propanamido]-3-sulfanylpropanamido]hexanoic acid

C25H37N7O6S (563.2526)


   

Gln Trp Lys Cys

(2R)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-(1H-indol-3-yl)propanamido]hexanamido]-3-sulfanylpropanoic acid

C25H37N7O6S (563.2526)


   

Trp Cys Lys Gln

(2S)-2-[(2S)-6-amino-2-[(2R)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-sulfanylpropanamido]hexanamido]-4-carbamoylbutanoic acid

C25H37N7O6S (563.2526)


   

Trp Cys Gln Lys

(2S)-6-amino-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-sulfanylpropanamido]-4-carbamoylbutanamido]hexanoic acid

C25H37N7O6S (563.2526)


   

Trp Lys Cys Gln

(2S)-2-[(2R)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]hexanamido]-3-sulfanylpropanamido]-4-carbamoylbutanoic acid

C25H37N7O6S (563.2526)


   

Trp Lys Gln Cys

(2R)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]hexanamido]-4-carbamoylbutanamido]-3-sulfanylpropanoic acid

C25H37N7O6S (563.2526)


   

Trp Gln Cys Lys

(2S)-6-amino-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-4-carbamoylbutanamido]-3-sulfanylpropanamido]hexanoic acid

C25H37N7O6S (563.2526)


   

Trp Gln Lys Cys

(2R)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-4-carbamoylbutanamido]hexanamido]-3-sulfanylpropanoic acid

C25H37N7O6S (563.2526)


   

Lasofoxifene tartrate

Lasofoxifene tartrate

C32H37NO8 (563.2519)


   

6-[3-[(E)-1-[4-[2-(dimethylamino)ethoxy]phenyl]-2-phenylbut-1-enyl]phenoxy]-3,4,5-trihydroxyoxane-2-carboxylic acid

6-[3-[(E)-1-[4-[2-(dimethylamino)ethoxy]phenyl]-2-phenylbut-1-enyl]phenoxy]-3,4,5-trihydroxyoxane-2-carboxylic acid

C32H37NO8 (563.2519)


   

2-{4-[(1Z)-1,2-diphenylbut-1-en-1-yl]phenoxy}-N,N-dimethylethanamine 2-hydroxypropane-1,2,3-tricarboxylate

2-{4-[(1Z)-1,2-diphenylbut-1-en-1-yl]phenoxy}-N,N-dimethylethanamine 2-hydroxypropane-1,2,3-tricarboxylate

C32H37NO8 (563.2519)


   

Alpha-Hydroxy-tamoxifen-O-glucuronide

Alpha-Hydroxy-tamoxifen-O-glucuronide

C32H37NO8 (563.2519)